HOME
About
What we do
Who We Are
Our Expertise
Our Partners
R&D
Novel microRNA therapeutics
Targeted delivery strategies
Companion Diagnostic Tools
CompamiR Project
MiRACULOUS Project
Careers
News
Contact

Theramir

HOME
About
What we do
Who We Are
Our Expertise
Our Partners
R&D
Novel microRNA therapeutics
Targeted delivery strategies
Companion Diagnostic Tools
CompamiR Project
MiRACULOUS Project
Careers
News
Contact
Costas Pitsillides
February 13, 2020

Publication of Theramir's international patent application on miRNA therapeutics

Costas Pitsillides
February 13, 2020

Theramir’s international patent application titled “MicroRNA-based therapy targeted against LCP-1 positive cancers” has been published under the Patent Cooperation Treaty (PCT). The patent is now in the last stage of the PCT process before entering the national granting phase (expected in February 2021).

TRMI-001-PCT - Publication 1st page.jpg
Newer PostCo-founder wins Madame Figaro Award
Older PostTheramir joins consortium of universities to secure €1m grant from the Research Promotion Foundation
Back to Top
Theramir Limited, 13 Georgiou Karaiskaki, Limassol, Limassol, 3032, Cyprus+357 99372914info@theramir.com